Key Events This Week
2 Feb: Stock hits 52-week low of Rs.104.4 amid sharp decline
6 Feb: Q2 FY26 results reveal profit surge despite revenue collapse
Week Close: Rs.119.50, up 3.96% for the week
Feb 06
BSE+NSE Vol: 9.46 k
Latest dividend: 0.5 per share ex-dividend date: Aug-29-2025
Uniphos Enterprises Ltd's latest financial results for Q2 FY26 present a complex picture characterized by significant operational challenges. The company reported a net profit of ₹23.16 crores, a notable turnaround from a loss of ₹0.74 crores in the previous quarter. However, this profit surge is primarily attributed to a substantial increase in other income, which reached ₹24.43 crores, overshadowing the complete absence of revenue from core operations, which stood at zero. This indicates a complete cessation of sales activity, raising concerns about the company's operational viability. The revenue figures reflect a dramatic decline, with net sales dropping from ₹5.86 crores in Q1 FY26 to zero in Q2 FY26, marking a 100% decrease quarter-on-quarter. This trend of erratic sales has been evident over the past several quarters, suggesting a deeply unstable operational environment. The company's return on equi...
Read full news article
2 Feb: Stock hits 52-week low of Rs.104.4 amid sharp decline
6 Feb: Q2 FY26 results reveal profit surge despite revenue collapse
Week Close: Rs.119.50, up 3.96% for the week

Uniphos Enterprises Ltd., a micro-cap speciality chemicals manufacturer with a market capitalisation of ₹837.00 crores, reported a paradoxical Q2 FY26 performance that has left investors grappling with conflicting signals. The company posted a net profit of ₹23.16 crores for the quarter ended September 2025, a remarkable turnaround from a loss of ₹0.74 crores in Q1 FY26. However, this apparent triumph conceals a deeply troubling operational reality: net sales collapsed to zero during the quarter, down 100.00% quarter-on-quarter and year-on-year, signalling a complete cessation of core business activity.
Read full news articleUniphos Enterprises Limited has informed the Exchange regarding Compliance under Regulation 23(9) of the SEBI (LODR) Regulations, 2015.
| Uniphos Enterprises Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 20, 2019. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results. |
| Uniphos Enterprises Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 20, 2019 |
No Upcoming Board Meetings
Uniphos Enterprises Ltd has declared 25% dividend, ex-date: 29 Aug 25
No Splits history available
No Bonus history available
Uniphos Enterprises Ltd has announced 173:100 rights issue, ex-date: 18 Sep 13
Promoters
None
Held by 3 Schemes (0.0%)
Held by 14 FIIs (15.71%)
Nerka Chemicals Pvt Ltd (73.28%)
Ares Diversified (4.56%)
8.94%
QoQ Growth in quarter ended Dec 2025 is 0.00% vs -100.00% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -104.36% vs 3,229.73% in Sep 2025
Growth in half year ended Sep 2025 is -82.51% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is 504.31% vs -90.55% in Sep 2024
YoY Growth in nine months ended Dec 2025 is -84.82% vs 0.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 1,057.30% vs -95.29% in Dec 2024
YoY Growth in year ended Mar 2025 is 120.16% vs 3,345.58% in Mar 2024
YoY Growth in year ended Mar 2025 is -99.27% vs -1.58% in Mar 2024